Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yunpeng Gao
Observed name:
Yun-peng Gao
Institutions:
Shaanxi University of Chinese Medicine,
The University of Texas Southwestern Medical Center
Observed institutions:
National Institutes of Health,
National Institute on Alcohol Abuse and Alcoholism,
Shaanxi University of Chinese Medicine,
The University of Texas Southwestern Medical Center
ORCID:
0000-0003-4746-4614
Observed ORCID:
0000-0003-4746-4614
OpenAlex ID:
A5070019748
BRD4 Promotes DNA Repair and Mediates the Formation of TMPRSS2-ERG Gene Rearrangements in Prostate Cancer
2018
·
Xiangyi Li
, GuemHee Baek
, et al.
·
Cell Reports
·
160
PDF
Androgen Receptor Variants Mediate DNA Repair after Prostate Cancer Irradiation
2017
·
Yi Yin
, Rui Li
, et al.
·
Cancer Research
·
70
The landscape of RNA polymerase II–associated chromatin interactions in prostate cancer
2020
·
Susmita G. Ramanand
, Yong Chen
, et al.
·
Journal of Clinical Investigation
·
64
PDF
PRMT5 is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancer
2024
·
Chang-Ching Lin
, Tsung-Cheng Chang
, et al.
·
Nature Communications
·
58
PDF
IFN-γ inhibits liver progenitor cell proliferation in HBV-infected patients and in 3,5-diethoxycarbonyl-1,4-dihydrocollidine diet-fed mice
2013
·
Hong-lei Weng
, De-chun Feng
, et al.
·
Journal of Hepatology
·
44
NLRP12 downregulates the Wnt/β-catenin pathway via interaction with STK38 to suppress colorectal cancer
2023
·
Shahanshah Khan
, Youn-Tae Kwak
, et al.
·
Journal of Clinical Investigation
·
39
FOXA2 suppresses endometrial carcinogenesis and epithelial-mesenchymal transition by regulating enhancer activity
2022
·
Subhransu S. Sahoo
, Susmita G. Ramanand
, et al.
·
Journal of Clinical Investigation
·
33
PDF
Critical role of antioxidant programs in enzalutamide-resistant prostate cancer
2023
·
Eliot B. Blatt
, Karla Parra
, et al.
·
Oncogene
·
21
PDF
ChIPr: accurate prediction of cohesin-mediated 3D genome organization from 2D chromatin features
2024
·
Ahmed Abbas
, Khyati Chandratre
, et al.
·
Genome biology
·
12
PDF
Targeting radioresistance and replication fork stability in prostate cancer
2022
·
Xiangyi Li
, GuemHee Baek
, et al.
·
JCI Insight
·
11
PDF
Methylenetetrahydrofolate reductase polymorphisms and colorectal cancer prognosis: A meta‐analysis
2019
·
Xin‐Lin Chen
, Yu‐Mei Wang
, et al.
·
The Journal of Gene Medicine
·
11
PDF
A distinct mechanism of epigenetic reprogramming silences PAX2 and initiates endometrial carcinogenesis
2025
·
Subhransu S. Sahoo
, Susmita G. Ramanand
, et al.
·
Journal of Clinical Investigation
·
10
National and subnational burden of brain and central nervous system cancers in China and global from 1990 to 2021: results from the global burden of disease study 2021
2025
·
Shifan Tu
, Xiaolu Huang
, et al.
·
Archives of Public Health
·
8
PDF
HIF-2–Dependent Regulation of PTHrP and Paraneoplastic Hypercalcemia in Aggressive Clear-Cell Renal Cell Carcinoma
2025
·
Arijit Mal
, Bingqing Xie
, et al.
·
Cancer Discovery
·
7
Genome-wide CRISPR screen identifies a cytokine-enhancer circuit driving HIF-2α activation in renal cancer
2026
·
Jun Fang
, Jeremy M. Simon
, et al.
·
Journal of Clinical Investigation
·
1
PDF
Corrigendum to Genome-wide CRISPR screen identifies a cytokine-enhancer circuit driving HIF-2α activation in renal cancer
2026
·
Jun Fang
, Jeremy M. Simon
, et al.
·
Journal of Clinical Investigation
Global research trends in the tumor microenvironment of glioma: insights from bibliometric analysis
2026
·
Xiaolu Huang
, Shifan Tu
, et al.
·
The Egyptian Journal of Neurology Psychiatry and Neurosurgery
PDF
Supplementary Table 1 from HIF-2–Dependent Regulation of PTHrP and Paraneoplastic Hypercalcemia in Aggressive Clear-Cell Renal Cell Carcinoma
2026
·
Arijit Mal
, Bingqing Xie
, et al.
Supplementary Figure 3 from HIF-2–Dependent Regulation of PTHrP and Paraneoplastic Hypercalcemia in Aggressive Clear-Cell Renal Cell Carcinoma
2026
·
Arijit Mal
, Bingqing Xie
, et al.
Supplementary Figure 5 from HIF-2–Dependent Regulation of PTHrP and Paraneoplastic Hypercalcemia in Aggressive Clear-Cell Renal Cell Carcinoma
2026
·
Arijit Mal
, Bingqing Xie
, et al.
Supplementary Figure 6 from HIF-2–Dependent Regulation of PTHrP and Paraneoplastic Hypercalcemia in Aggressive Clear-Cell Renal Cell Carcinoma
2026
·
Arijit Mal
, Bingqing Xie
, et al.
Supplementary Figure 4 from HIF-2–Dependent Regulation of PTHrP and Paraneoplastic Hypercalcemia in Aggressive Clear-Cell Renal Cell Carcinoma
2026
·
Arijit Mal
, Bingqing Xie
, et al.
Supplementary Figure 10 from HIF-2–Dependent Regulation of PTHrP and Paraneoplastic Hypercalcemia in Aggressive Clear-Cell Renal Cell Carcinoma
2026
·
Arijit Mal
, Bingqing Xie
, et al.
Supplementary Figure 7 from HIF-2–Dependent Regulation of PTHrP and Paraneoplastic Hypercalcemia in Aggressive Clear-Cell Renal Cell Carcinoma
2026
·
Arijit Mal
, Bingqing Xie
, et al.
Supplementary Table 4-10 from HIF-2–Dependent Regulation of PTHrP and Paraneoplastic Hypercalcemia in Aggressive Clear-Cell Renal Cell Carcinoma
2026
·
Arijit Mal
, Bingqing Xie
, et al.
Show more works
View as search
Works count:
37
Citation count:
549
H-index:
11
I10-index:
12
Year
Topic
Type